Fredrikson & Byron Represents Bio-Techne in Agreement to Acquire ProteinSimple
Fredrikson & Byron acted as legal counsel to Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, a company engaged in the development, manufacture and sale of biotechnology products and clinical calibrators and controls, in its agreement to acquire ProteinSimple for $300 million in cash.